3×5 Partners has closed 3×5 Partners Fund III, LP with $100 million in capital commitments.

Based in Portland, Oregon, 3×5 has raised over $400 million and has delivered both top returns to investors and meaningful impact to the world.

“Our goal has always been to significantly improve the lives of people and help humanity be better stewards of the planet. Protecting the shared health of the planet and its people is more critical than ever. We believe deeply that, far from being an encumbrance, investing in essential solutions is the source of our performance,” states Nicholas Walrod, co-founder and Managing Director at 3×5. “We at 3×5 are incredibly thankful to individuals, families, and institutions who have trusted us with their capital. We will continue to serve as business building partners for our entrepreneurs, generate top returns for our limited partners, and deliver breakthrough solutions for our world.”

In service of 3×5’s mission to “Invest in what the world needs”, 3×5 Fund III is already an investor in five companies: Adarza BioSystems, Arch Oncology, Fervo Energy, Good Therapeutics, and Intervene.

With over $400 million raised, 3×5 Partners is a venture capital firm that collaborates with passionate entrepreneurs developing solutions to our global health and climate crises.